| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/28/2005 | US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase |
| 07/28/2005 | US20050165103 for enhancing the endogenous production of interleukin-10 (IL-10) and suppressing the production of interleukin-2 in mammalian cells or tissues; inhibiting the proliferation of stimulated peripheral mononuclear cells |
| 07/28/2005 | US20050165087 Nf-kb inhibitors |
| 07/28/2005 | US20050165086 Aminothiophene inhibitors of NF- kappa B inhibitors for treatment of diseases such as cancer or aids |
| 07/28/2005 | US20050165077 Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage |
| 07/28/2005 | US20050165066 Antiproliferative agents |
| 07/28/2005 | US20050165063 Amine compounds and use thereof |
| 07/28/2005 | US20050165052 combining substituted quinolines with a carrier; leishmania/HIV infection; viricide, parasiticide |
| 07/28/2005 | US20050165040 Beta-carboline hydroxamic acid substituted pyrido 3,4-B indole compounds; 9-(4-fluorobenzyl)-N-hydroxy-9H- beta -carboline-3-carboxamide |
| 07/28/2005 | US20050165039 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 07/28/2005 | US20050165019 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 07/28/2005 | US20050165017 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050165007 Benzimidazoles and analogs thereof as antivirals |
| 07/28/2005 | US20050165000 Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant |
| 07/28/2005 | US20050164989 Novel $g(a)-amino-n-(diaminophosphinyl) lactam derivative |
| 07/28/2005 | US20050164988 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia |
| 07/28/2005 | US20050164964 Mixture of a nucleic acid and a chitosan with branching groups attached to the amino group, selected from alkyl groups with 2 or more carbon atoms, monosaccharides, oligosaccharides or polysaccharides; gene therapy, genetic vaccines, antisense therapy, anticarcinogenic agents, autoimmune diseases |
| 07/28/2005 | US20050164960 Administering substituted (beta -D-ribofuranosyl)purines or (beta -D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidines alone or incombination with cidofovir, ribavirin, levovirin, or viramidine, particularly against vaccinia virus or variola virus infections |
| 07/28/2005 | US20050164936 Antiinflammatory and antitumor agents; human T-cell leukemia/lymphoma virus and lymphadenopathy associated virus treatment; angiogenic- or hematopoiesis-related diseases; medical diagnosis |
| 07/28/2005 | US20050164926 Novel recombinant anticoagulant proteins |
| 07/28/2005 | US20050164919 Bactericides; peptide antibiotics |
| 07/28/2005 | US20050164916 Glycopeptide phosphonate derivatives |
| 07/28/2005 | US20050164234 Antisense therapy; gene expression inhibition |
| 07/28/2005 | US20050164233 Compositions, kits and methods for identification and modulation of type I diabetes |
| 07/28/2005 | US20050164185 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta |
| 07/28/2005 | US20050164164 Hiv-1 virus tat-protein mutants |
| 07/28/2005 | US20050163888 dairy products containing Lactobacillus gasseri used for prophylaxis and/or therapy of gastrointestinal disorders such as ulcers |
| 07/28/2005 | US20050163878 Therapeutic agent of skin diseases |
| 07/28/2005 | US20050163862 Suppressing cytokine secretion with such as sodium selenite; by the reduction in extra- and intracellular oxidative stress |
| 07/28/2005 | US20050163859 Injectable compositions for the controlled delivery of pharmacologically active compound |
| 07/28/2005 | US20050163808 Group A streptococcal polysaccharide immunogenic compositions and methods |
| 07/28/2005 | US20050163804 Containing transcriptional units which encode a signal sequence of one flavivirus and an immunogenic flavivirus antigen of a second flavivirus; Japanese encephalitis virus (JEV), West Nile virus (WNV) or related flaviviruses |
| 07/28/2005 | US20050163794 Immunological herpes simplex virus antigens and methods for use thereof |
| 07/28/2005 | US20050163770 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 07/28/2005 | US20050163767 useful as a diagnostic marker or a drug target for bronchial asthma, chronic obstructive pulmonary disease; isolated antibody which specifically binds to a specific protein belonging to the chitinase family |
| 07/28/2005 | US20050163757 Anti-microbial biotherapeutic agents: alternatives to conventional pharmaceutical antibiotics |
| 07/28/2005 | US20050163751 Synergistic mixture with compounds such as interferon, paclitaxel or P-16; side effect reduction |
| 07/28/2005 | US20050163727 Topical, oral administration; mouthrinses; microbiocides; bactericides; prevents spread of pathogenic oral bacteria, toxins and endotoxins, and resultant inflammatory cytokines and mediators; cardiovascular disease, stroke, atherosclerosis |
| 07/28/2005 | DE10361945A1 Pharmaceutical preparation for the treatment of e.g. severe acute respiratory syndrome |
| 07/28/2005 | DE10206849A1 Phenalenon-Derivate, Verfahren zur Herstellung und Verwendung derselben Phenalenone derivatives, to processes for preparing and using the same |
| 07/28/2005 | CA2552965A1 Carboxamide derivative and use thereof |
| 07/28/2005 | CA2552002A1 Azabenzofuran substituted thioureas as inhibitors of viral replication |
| 07/27/2005 | EP1557428A1 Antibodies against a human stromal derived factor (SDF) and pharmaceutical composition containing them |
| 07/27/2005 | EP1557424A1 Bi-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| 07/27/2005 | EP1557421A1 Polymorphous forms of rifaximin as antibiotics |
| 07/27/2005 | EP1557416A1 Oxazolidinone-quinolone hybrid antibiotics |
| 07/27/2005 | EP1557410A2 Bacterial gyrase inhibitors and uses thereof |
| 07/27/2005 | EP1557197A1 Dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity |
| 07/27/2005 | EP1557167A1 Viral inhibition by long-chain alcohols alkanes fatty acids and amides |
| 07/27/2005 | EP1556477A2 Drying process |
| 07/27/2005 | EP1556401A2 22 human secreted proteins |
| 07/27/2005 | EP1556399A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 07/27/2005 | EP1556398A1 Novel cytarabine monophosphate prodrugs |
| 07/27/2005 | EP1556393A2 Novel cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs |
| 07/27/2005 | EP1556389A1 Cephem compounds |
| 07/27/2005 | EP1556381A1 Pyrazole amides for treating hiv infections |
| 07/27/2005 | EP1556371A2 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
| 07/27/2005 | EP1556369A1 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2005 | EP1556141A1 Method for the prophylaxis and therapy of mycoses in fish and invertebrates and the development stages thereof |
| 07/27/2005 | EP1556081A2 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 07/27/2005 | EP1556077A2 Use of cpg oligonucleotides in the treatment of hepatitis c virus infection |
| 07/27/2005 | EP1556074A2 Casein derived peptides and uses thereof in therapy |
| 07/27/2005 | EP1556066A2 Compositions and methods of use for a fibroblast growth factor |
| 07/27/2005 | EP1556050A1 Pharmaceutical compositions of ganciclovir |
| 07/27/2005 | EP1556035A2 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 07/27/2005 | EP1556033A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 07/27/2005 | EP1556021A1 Pharmaceutical compositions comprising flavonoids and menthol |
| 07/27/2005 | EP1556008A1 Use of bases for the manufacture of a medicament in the treatment of different forms of inflammatory dermatosis |
| 07/27/2005 | EP1387837B1 Novel azole or triazole derivatives, method for preparing same and use thereof as antifungal medicines |
| 07/27/2005 | EP1379523B1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 07/27/2005 | EP1377573B1 Pyrazolopyridine derivatives |
| 07/27/2005 | EP1283823A4 Novel mmp-2/mmp-9 inhibitors |
| 07/27/2005 | EP1283709B1 Peptide deformylase inhibitors |
| 07/27/2005 | EP1263757B1 Benzthiazoles as tnf and pde-iv inhibitors |
| 07/27/2005 | EP0935462B1 Photopheresis treatment of leukocytes |
| 07/27/2005 | EP0682707B1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 07/27/2005 | CN2712931Y Electromagnetic cleavage device for cleavage extracting polypeptide from vegetable protein |
| 07/27/2005 | CN1646684A Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 07/27/2005 | CN1646566A Induction of anti-tumor CTL immunity through in vivo triggering of 4-1BB and/or CD40 |
| 07/27/2005 | CN1646560A Nucleotide sequence coding for a ToIC containing a heterologous amino acid sequence |
| 07/27/2005 | CN1646558A Histone deacetylase inhibitors and process for producing the same |
| 07/27/2005 | CN1646556A Blanched polyamine steroid derivatives |
| 07/27/2005 | CN1646537A Phosphorus-containing compounds & uses thereof |
| 07/27/2005 | CN1646534A Modified fluorinated nucleoside analogues |
| 07/27/2005 | CN1646526A Tropane derivatives as CCR5 modulators |
| 07/27/2005 | CN1646520A 1, 3, 5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 07/27/2005 | CN1646513A An antimicrobial agent |
| 07/27/2005 | CN1646508A 5-substituted 1, 1-dioxo-1, 2, 5-thiazolidine-3-one derivatives as PTP ase 1B inhibitors |
| 07/27/2005 | CN1646505A Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/27/2005 | CN1646499A Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 07/27/2005 | CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators |
| 07/27/2005 | CN1646495A Amine compounds and use thereof |
| 07/27/2005 | CN1646480A Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 07/27/2005 | CN1646473A Novel curcumin analogues and uses thereof |
| 07/27/2005 | CN1646158A Modified vaccinia virus ankara for the vaccination of neonates |
| 07/27/2005 | CN1646157A Multiple and multivalent DNA vaccines in ovo |
| 07/27/2005 | CN1646156A Strategy for retroviral immunotherapy |
| 07/27/2005 | CN1646154A Albumin-fused anti-angiogenesis peptides |
| 07/27/2005 | CN1646152A Mannose binding lectin and uses thereof |